DCGI rejects Dr Reddy’s proposal seeking change in regulatory approval status for remdesivir

Dr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeking permissions for new drugs, clinical trials, vaccines for Covid-19.